Sestina Bio to develop digital cell engineering platform

By The Science Advisory Board staff writers

October 15, 2020 -- Sestina Bio, a new company developing an automated synthetic biology platform, has been launched with seed funding. Sestina also is the first company to be launched from the Foresite Labs incubator.

Funding was provided by Foresite Capital, General Inception, and OMX Ventures and will be used to develop digital cellular engineering and phenotyping platforms and support initial product development.

The platforms will include instruments for single-cell genome editing, tools for single-cell phenotyping, and closed-loop machine learning-driven design and control of experiments, which cumulatively will form the next generation of automated synthetic biology toolkits.


Copyright © 2020 scienceboard.net
 

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a Scienceboard.net password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?